Matrix metalloproteinase 2-sensitive multifunctional polymeric micelles for tumor-specific co-delivery of siRNA and hydrophobic drugs

Song, 2003, RNA interference targeting Fas protects mice from fulminant hepatitis, Nat Med, 9, 347, 10.1038/nm828 de Fougerolles, 2007, Interfering with disease: a progress report on siRNA-based therapeutics, Nat Rev Drug Discov, 6, 443, 10.1038/nrd2310 Oh, 2009, siRNA delivery systems for cancer treatment, Adv Drug Deliv Rev, 61, 850, 10.1016/j.addr.2009.04.018 De Paula, 2007, Hydrophobization and bioconjugation for enhanced siRNA delivery and targeting, Rna, 13, 431, 10.1261/rna.459807 Zhu, 2010, Lipid and polymeric carrier-mediated nucleic acid delivery, Expert Opin Drug Deliv, 7, 1209, 10.1517/17425247.2010.513969 Sawant, 2012, Polyethyleneimine-lipid conjugate-based pH-sensitive micellar carrier for gene delivery, Biomaterials, 33, 3942, 10.1016/j.biomaterials.2011.11.088 Navarro, 2012, P-glycoprotein silencing with siRNA delivered by DOPE-modified PEI overcomes doxorubicin resistance in breast cancer cells, Nanomedicine (Lond), 7, 65, 10.2217/nnm.11.93 Wang, 2006, Co-delivery of drugs and DNA from cationic core-shell nanoparticles self-assembled from a biodegradable copolymer, Nat Mater, 5, 791, 10.1038/nmat1737 Sun, 2011, Simultaneous delivery of siRNA and paclitaxel via a “two-in-one” micelleplex promotes synergistic tumor suppression, ACS Nano, 5, 1483, 10.1021/nn103349h Chen, 2009, Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells, Small, 5, 2673, 10.1002/smll.200900621 Zhu, 2013, Stimulus-responsive nanopreparations for tumor targeting, Integr Biol, 5, 96, 10.1039/C2IB20135F Zhu, 2012, Matrix metalloprotease 2-responsive multifunctional liposomal nanocarrier for enhanced tumor targeting, ACS Nano, 6, 3491, 10.1021/nn300524f Zhu, 2013, Enhanced anticancer activity of nanopreparation containing an MMP2-sensitive PEG-drug conjugate and cell-penetrating moiety, Proc Natl Acad Sci U S A, 110, 17047, 10.1073/pnas.1304987110 Kortylewski, 2005, Inhibiting Stat3 signaling in the hematopoietic system elicits multicomponent antitumor immunity, Nat Med, 11, 1314, 10.1038/nm1325 Lukyanov, 2004, Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs, Adv Drug Deliv Rev, 56, 1273, 10.1016/j.addr.2003.12.004 Walkey, 2012, Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake, J Am Chem Soc, 134, 2139, 10.1021/ja2084338 Ambrosini, 1997, A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma, Nat Med, 3, 917, 10.1038/nm0897-917 Altieri, 2003, Survivin, versatile modulation of cell division and apoptosis in cancer, Oncogene, 22, 8581, 10.1038/sj.onc.1207113 Zhu, 2010, Targeted delivery of siRNA to hepatocytes and hepatic stellate cells by bioconjugation, Bioconjug Chem, 21, 2119, 10.1021/bc100346n Li, 2006, Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells, Mol Pharmacol, 3, 579, 10.1021/mp060039w Salzano, 2014, Polymeric micelles containing reversibly phospholipid-modified anti-survivin siRNA: a promising strategy to overcome drug resistance in cancer, Cancer Lett, 343, 224, 10.1016/j.canlet.2013.09.037 Shen, 2012, Co-delivery of paclitaxel and survivin shRNA by pluronic P85-PEI/TPGS complex nanoparticles to overcome drug resistance in lung cancer, Biomaterials, 33, 8613, 10.1016/j.biomaterials.2012.08.007 Kirpotin, 2006, Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models, Cancer Res, 66, 6732, 10.1158/0008-5472.CAN-05-4199 Zorko, 2005, Cell-penetrating peptides: mechanism and kinetics of cargo delivery, Adv Drug Deliv Rev, 57, 529, 10.1016/j.addr.2004.10.010 Cabral, 2011, Accumulation of sub-100 nm polymeric micelles in poorly permeable tumours depends on size, Nat Nanotechnol, 6, 815, 10.1038/nnano.2011.166